These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16130444)

  • 21. Pediatric nonalcoholic fatty liver disease in 2009.
    Alisi A; Manco M; Vania A; Nobili V
    J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and therapy of nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Gastroenterology; 2008 May; 134(6):1682-98. PubMed ID: 18471547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
    Podymova SD
    Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis.
    Baranova A; Younossi ZM
    Hepatology; 2008 Feb; 47(2):373-5. PubMed ID: 18220279
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohistochemical analysis in steatohepatitis: does it have a role in diagnosis and management?
    Snover D
    Am J Clin Pathol; 2005 Apr; 123(4):491-3. PubMed ID: 15743741
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S; Kleiner DE; Goodman ZD; Gramlich T; Younossi ZM
    Clin Liver Dis; 2007 Feb; 11(1):17-23, vii. PubMed ID: 17544969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of and therapy for nonalcoholic steatohepatitis].
    Onishi S; Saibara T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1876-80. PubMed ID: 17037330
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
    Bookman ID; Pham J; Guindi M; Heathcote EJ
    Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and management of non-alcoholic steatohepatitis.
    Ramesh S; Sanyal AJ
    J Hepatol; 2005; 42 Suppl(1):S2-12. PubMed ID: 15777569
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediatric nonalcoholic fatty liver disease.
    Lerret SM; Skelton JA
    Gastroenterol Nurs; 2008; 31(2):115-9. PubMed ID: 18391799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.